202 related articles for article (PubMed ID: 22050182)
1. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.
Kim JS; Kim IK; Lee SY; Song BW; Cha MJ; Song H; Choi E; Lim S; Ham O; Jang Y; Hwang KC
Cell Biol Int; 2012 Mar; 36(3):305-10. PubMed ID: 22050182
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
Gao D; Hao G; Meng Z; Ning N; Yang G; Liu Z; Dong X; Niu X
PLoS One; 2015; 10(4):e0123724. PubMed ID: 25874449
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.
Gao DF; Niu XL; Hao GH; Peng N; Wei J; Ning N; Wang NP
Biochem Pharmacol; 2007 Jan; 73(2):185-97. PubMed ID: 17074304
[TBL] [Abstract][Full Text] [Related]
4. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
Hwang YJ; Park JH; Cho DH
J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
6. Role of IκB kinase-β in the growth-promoting effects of angiotensin II in vitro and in vivo.
Doyon P; van Zuylen WJ; Servant MJ
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2850-7. PubMed ID: 24135021
[TBL] [Abstract][Full Text] [Related]
7. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Ren L; Liu N; Zhi H; Li Y; Li Y; Tang R; Sheng Z
Cardiovasc Diabetol; 2011 Jan; 10():10. PubMed ID: 21269478
[TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of TRPM7 channels by angiotensin II triggers phenotypic switching of vascular smooth muscle cells of ascending aorta.
Zhang Z; Wang M; Fan XH; Chen JH; Guan YY; Tang YB
Circ Res; 2012 Oct; 111(9):1137-46. PubMed ID: 22896586
[TBL] [Abstract][Full Text] [Related]
10. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1.
Benkirane K; Amiri F; Diep QN; El Mabrouk M; Schiffrin EL
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H390-7. PubMed ID: 16155101
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway.
Park S; Lim S; Chang W; Song H; Lee S; Song BW; Kim HJ; Cha MJ; Choi E; Jang Y; Chung N; Cho SY; Hwang KC
Yonsei Med J; 2008 Aug; 49(4):592-600. PubMed ID: 18729301
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-761 inhibits Angiotensin II-induced vascular smooth muscle cell proliferation and migration by targeting mammalian target of rapamycin.
Cho JR; Lee CY; Lee J; Seo HH; Choi E; Chung N; Kim SM; Hwang KC; Lee S
Clin Hemorheol Microcirc; 2015 Sep; 63(1):45-56. PubMed ID: 26444612
[TBL] [Abstract][Full Text] [Related]
13. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
14. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
Ji Y; Liu J; Wang Z; Liu N; Gou W
Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898
[TBL] [Abstract][Full Text] [Related]
15. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.
Sung JY; Choi HC
Vascul Pharmacol; 2012; 56(1-2):1-8. PubMed ID: 21708289
[TBL] [Abstract][Full Text] [Related]
16. Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells.
Ren XY; Ruan QR; Zhu DH; Zhu M; Qu ZL; Lu J
Sheng Li Xue Bao; 2007 Jun; 59(3):339-44. PubMed ID: 17579790
[TBL] [Abstract][Full Text] [Related]
17. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
18. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P
Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613
[TBL] [Abstract][Full Text] [Related]
19. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
Li PG; Xu JW; Ikeda K; Kobayakawa A; Kayano Y; Mitani T; Ikami T; Yamori Y
Hypertens Res; 2005 Apr; 28(4):369-77. PubMed ID: 16138568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
